methoxyhydroxyphenylglycol has been researched along with Depression, Involutional in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Cao, T; Chen, Q; Jiao, S; Wang, L; Wu, X; Yang, C; Yang, D; Yang, P; Zeng, C; Zhang, S; Zhu, Z | 1 |
| Igata, R; Ikenouchi, A; Natsuyama, T; Okamoto, N; Yoshimura, R | 1 |
| Forman, J; Kessing, LV; Knorr, U; Pech, J | 1 |
| Kunugi, H; Ogawa, S; Tsuchimine, S | 1 |
| Cubała, WJ; Czarnowski, W; Landowski, J; Wielgomas, B | 1 |
| Boldrini, M; Cooper, TB; Currier, D; Ellis, SP; Malone, KM; Mann, JJ; Oquendo, MA; Sullivan, G; Watson, KT; Xie, S | 1 |
| Currier, D; Galfalvy, H; Huang, YY; Mann, JJ; Oquendo, MA | 1 |
| Currier, D; Galfalvy, H; Huang, YY; John Mann, J; Oquendo, MA; Sullivan, G | 1 |
| Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Otani, K; Suzuki, A; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Granérus, AK; Mårtensson, B; Pålhagen, S; Qi, H; Svenningsson, P; Wålinder, J | 1 |
| Castro, WL; Delgado, PL; El Khoury, A; Mathé, AA; Misiaszek, J; Moreno, FA; Palmer, C; Parkinson, D; Wright, R | 1 |
| Atake, K; Katsuki, A; Nakamura, J; Tokutsu, Y; Umene-Nakano, W; Yoshimura, R | 1 |
| Egami, M; Imamura, Y; Mizoguchi, Y; Nabeta, H; Yamada, S | 1 |
| Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Lima, L; Manzano, E; Mata, S; Ortiz, T; Urbina, M | 1 |
| Nakamura, J; Ueda, N; Yoshimura, R; Yukimasa, T | 1 |
| Brent, D; Currier, D; Galfalvy, H; Greenhill, L; Huang, YY; Mann, JJ; Murphy, L; Oquendo, M | 1 |
| Hori, H; Mitoma, M; Miyamoto, K; Nakamura, J; Sugita, A; Ueda, N; Umene, W; Yoshimura, R | 1 |
| Ellis, SP; Huang, YY; Malone, KM; Mann, JJ; Oquendo, MA; Placidi, GP | 1 |
| Besio, G; Loeb, C; Roccatagliatà, G | 1 |
2 review(s) available for methoxyhydroxyphenylglycol and Depression, Involutional
| Article | Year |
|---|---|
Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Young Adult | 2018 |
Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Topics: Biomarkers; Depressive Disorder, Major; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol | 2018 |
4 trial(s) available for methoxyhydroxyphenylglycol and Depression, Involutional
| Article | Year |
|---|---|
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Severity of Illness Index; Treatment Outcome; Young Adult | 2010 |
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.
Topics: Adult; Analysis of Variance; Case-Control Studies; Chromatography, High Pressure Liquid; Circadian Rhythm; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Electrochemistry; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Indoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurochemistry; Neuropeptide Y; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Tryptophan; Young Adult | 2010 |
Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2002 |
Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.
Topics: Adult; Aged; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cotinine; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Smoking; Tobacco Use Disorder; Treatment Outcome | 2007 |
14 other study(ies) available for methoxyhydroxyphenylglycol and Depression, Involutional
| Article | Year |
|---|---|
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Biomarkers; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin; Tryptophan; Vanilmandelic Acid | 2022 |
The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.
Topics: Catecholamines; Depression; Depressive Disorder, Major; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Nitric Oxide | 2022 |
Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Receptors, Adrenergic; Saliva; Young Adult | 2014 |
Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.
Topics: Adult; Age Factors; Anxiety; Bipolar Disorder; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Severity of Illness Index; Young Adult | 2014 |
Increased risk of suicide attempt in mood disorders and TPH1 genotype.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Black or African American; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Haplotypes; Hispanic or Latino; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mood Disorders; New York; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Sex Factors; Suicide, Attempted; Tryptophan Hydroxylase; White People; Young Adult | 2009 |
Lower CSF MHPG predicts short-term risk for suicide attempt.
Topics: Adult; Biomarkers; Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Suicide, Attempted; Time Factors | 2009 |
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.
Topics: Aged; Analysis of Variance; Biogenic Monoamines; Brain-Derived Neurotrophic Factor; Corticosterone; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Radioimmunoassay | 2010 |
The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
Topics: Depressive Disorder, Major; Electroconvulsive Therapy; Ethylene Glycols; Homovanillic Acid; Humans; Hyperprolactinemia; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenols; Psychiatric Status Rating Scales | 2012 |
Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
Topics: Adult; Aged; Biomarkers; Depressive Disorder, Major; Female; Humans; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Mirtazapine; Saliva; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2013 |
Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression.
Topics: Adult; Blood Platelets; Cell Membrane; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Lymphocytes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin | 2005 |
[Therapeutic effectiveness of transcranial magnetic stimulation for intractable depressive disorders-- blood catecholamines and BDNF].
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Transcranial Magnetic Stimulation | 2007 |
No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
Topics: Adult; Bipolar Disorder; Child; Child Abuse; Depressive Disorder, Major; Female; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Suicide, Attempted; Tryptophan Hydroxylase | 2008 |
Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
Topics: Adult; Aggression; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Suicide, Attempted | 2001 |
[Variations in the urinary level of MHPG in depressive syndromes].
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Anxiety; Depression; Depressive Disorder; Depressive Disorder, Major; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Perphenazine; Recurrence; Trazodone; Viloxazine | 1979 |